A dexamethasone implant significantly outperformed ranibizumab (Lucentis) and methotrexate for intravitreal treatment of persistent/recurrent uveitic macular edema, according to results of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback